+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

C-myc and p53 Expression DNA-ploidy and proliferative activity in non-mucinous ovarian carcinomas



C-myc and p53 Expression DNA-ploidy and proliferative activity in non-mucinous ovarian carcinomas



Pathology Research & Practice 190(3): 270




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030370368

Download citation: RISBibTeXText


Related references

DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosis. Virchows Archiv 429(4-5): 221-227, 1996

Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary. International Journal of Gynecological Pathology 24(1): 67-72, 2005

Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Modern Pathology 19(11): 1421-1428, 2006

High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors. Cancer 94(9): 2454-2465, 2002

A novel algorithm for better distinction of primary mucinous ovarian carcinomas and mucinous carcinomas metastatic to the ovary. Virchows Archiv 2019, 2019

Cytophotometric measurements of nuclear DNA content of bronchogenic carcinomas. II. The DNA ploidy and proliferative activity of bronchogenic carcinomas. Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association 84(7): 785-792, 1985

Matching maternal isodisomy in mucinous carcinomas and associated ovarian teratomas provides evidence of germ cell derivation for some mucinous ovarian tumors. American Journal of Surgical Pathology 37(8): 1229-1235, 2013

Flow cytometric measurement of ploidy and proliferative activity of carcinomas of the oropharyngeal mucosa. Archives of Dermatological Research 273(1-2): 121-128, 1982

HER2 expression in ovarian mucinous carcinomas in Tunisia. Asian Pacific Journal of Cancer Prevention 15(19): 8121-8125, 2015

Correlation between nucleolar organizer regions ploidy status and proliferative activity in primary breast carcinomas. International Journal of Biological Markers 6(1): 69, 1991

The significance of ploidy and proliferative activity on survival in ovarian cancer. Journal of Cancer Research and Clinical Oncology 111(1 Supplement): S133-0, 1986

Usefulness of proliferative activity, DNA ploidy pattern and p53 products as diagnostic adjuncts in colorectal adenomas and intramucosal carcinomas. Pathology International 49(7): 617-625, 1999

Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. American Journal of Surgical Pathology 23(6): 617-635, 1999

Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. International Journal of Gynecological Pathology 21(4): 391-400, 2002

Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas. Human Pathology. 26(1): 3-11, 1995